Clinical trial NCT01303081 - References

Tobacco Use Disorder — Pilot Randomized Control Trial of Financial Incentives for Smoking Cessation

Citation(s)

•   Audrain J, Boyd NR, Roth J, Main D, Caporaso NF, Lerman C
  Genetic susceptibility testing in smoking-cessation treatment: one-year outcomes of a randomized trial. Addict Behav. 1997 Nov-Dec;22(6):741-51.
•   Audrain-McGovern J, Rodriguez D, Epstein LH, Cuevas J, Rodgers K, Wileyto EP
  Does delay discounting play an etiological role in smoking or is it a consequence of smoking? Drug Alcohol Depend. 2009 Aug 1;103(3):99-106. doi: 10.1016/j.drugalcdep.2008.12.019. Epub 2009 May 14.
•   Audrain-McGovern J, Rodriguez D, Epstein LH, Rodgers K, Cuevas J, Wileyto EP
  Young adult smoking: what factors differentiate ex-smokers, smoking cessation treatment seekers and nontreatment seekers? Addict Behav. 2009 Dec;34(12):1036-41. doi: 10.1016/j.addbeh.2009.06.012. Epub 2009 Jul 5.
•   Baker F, Johnson MW, Bickel WK
  Delay discounting in current and never-before cigarette smokers: similarities and differences across commodity, sign, and magnitude. J Abnorm Psychol. 2003 Aug;112(3):382-92.
•   Bickel WK, Odum AL, Madden GJ
  Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl). 1999 Oct;146(4):447-54.
•   Brownson RC, Eriksen MP, Davis RM, Warner KE
  Environmental tobacco smoke: health effects and policies to reduce exposure. Annu Rev Public Health. 1997;18:163-85. Review.
•   Centers for Disease Control and Prevention (CDC)
  Cigarette smoking among adults and trends in smoking cessation - United States, 2008. MMWR Morb Mortal Wkly Rep. 2009 Nov 13;58(44):1227-32.
•   Centers for Disease Control and Prevention (CDC)
  State-specific smoking-attributable mortality and years of potential life lost--United States, 2000-2004. MMWR Morb Mortal Wkly Rep. 2009 Jan 23;58(2):29-33. Erratum in: MMWR Morb Mortal Wkly Rep. 2009 Feb 6;58(4):91.
•   Coffield AB, Maciosek MV, McGinnis JM, Harris JR, Caldwell MB, Teutsch SM, Atkins D, Richland JH, Haddix A
  Priorities among recommended clinical preventive services. Am J Prev Med. 2001 Jul;21(1):1-9.
•   Cromwell J, Bartosch WJ, Fiore MC, Hasselblad V, Baker T
  Cost-effectiveness of the clinical practice recommendations in the AHCPR guideline for smoking cessation. Agency for Health Care Policy and Research. JAMA. 1997 Dec 3;278(21):1759-66.
•   Delmonico FL, Arnold R, Scheper-Hughes N, Siminoff LA, Kahn J, Youngner SJ
  Ethical incentives--not payment--for organ donation. N Engl J Med. 2002 Jun 20;346(25):2002-5.
•   Dickert N, Grady C
  What's the price of a research subject? Approaches to payment for research participation. N Engl J Med. 1999 Jul 15;341(3):198-203.
•   DiClemente CC, Prochaska JO, Fairhurst SK, Velicer WF, Velasquez MM, Rossi JS
  The process of smoking cessation: an analysis of precontemplation, contemplation, and preparation stages of change. J Consult Clin Psychol. 1991 Apr;59(2):295-304.
•   Donatelle R, Hudson D, Dobie S, Goodall A, Hunsberger M, Oswald K
  Incentives in smoking cessation: status of the field and implications for research and practice with pregnant smokers. Nicotine Tob Res. 2004 Apr;6 Suppl 2:S163-79. Review.
•   Donatelle RJ, Prows SL, Champeau D, Hudson D
  Randomised controlled trial using social support and financial incentives for high risk pregnant smokers: significant other supporter (SOS) program. Tob Control. 2000;9 Suppl 3:III67-9.
•   Giuffrida A, Torgerson DJ
  Should we pay the patient? Review of financial incentives to enhance patient compliance. BMJ. 1997 Sep 20;315(7110):703-7. Review.
•   Greenland S, Schwartzbaum JA, Finkle WD
  Problems due to small samples and sparse data in conditional logistic regression analysis. Am J Epidemiol. 2000 Mar 1;151(5):531-9. Review.
•   Halpern SD, Karlawish JH, Casarett D, Berlin JA, Asch DA
  Empirical assessment of whether moderate payments are undue or unjust inducements for participation in clinical trials. Arch Intern Med. 2004 Apr 12;164(7):801-3.
•   Halpern SD, Madison KM, Volpp KG
  Patients as mercenaries?: the ethics of using financial incentives in the war on unhealthy behaviors. Circ Cardiovasc Qual Outcomes. 2009 Sep;2(5):514-6. doi: 10.1161/CIRCOUTCOMES.109.871855.
•   Halpern SD, Raz A, Kohn R, Rey M, Asch DA, Reese P
  Regulated payments for living kidney donation: an empirical assessment of the ethical concerns. Ann Intern Med. 2010 Mar 16;152(6):358-65. doi: 10.7326/0003-4819-152-6-201003160-00005.
•   Hatsukami DK, Stead LF, Gupta PC
  Tobacco addiction. Lancet. 2008 Jun 14;371(9629):2027-38. doi: 10.1016/S0140-6736(08)60871-5. Review.
•   Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO
  The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict. 1991 Sep;86(9):1119-27.
•   Hennrikus DJ, Jeffery RW, Lando HA, Murray DM, Brelje K, Davidann B, Baxter JS, Thai D, Vessey J, Liu J
  The SUCCESS project: the effect of program format and incentives on participation and cessation in worksite smoking cessation programs. Am J Public Health. 2002 Feb;92(2):274-9.
•   Higgins ST, Heil SH, Dantona R, Donham R, Matthews M, Badger GJ
  Effects of varying the monetary value of voucher-based incentives on abstinence achieved during and following treatment among cocaine-dependent outpatients. Addiction. 2007 Feb;102(2):271-81.
•   Hughes JR
  Motivating and helping smokers to stop smoking. J Gen Intern Med. 2003 Dec;18(12):1053-7. Review.
•   Hymowitz N, Cummings KM, Hyland A, Lynn WR, Pechacek TF, Hartwell TD
  Predictors of smoking cessation in a cohort of adult smokers followed for five years. Tob Control. 1997;6 Suppl 2:S57-62.
•   Jacob P 3rd, Wilson M, Benowitz NL
  Improved gas chromatographic method for the determination of nicotine and cotinine in biologic fluids. J Chromatogr. 1981 Jan 2;222(1):61-70.
•   Jacob P 3rd, Yu L, Wilson M, Benowitz NL
  Selected ion monitoring method for determination of nicotine, cotinine and deuterium-labeled analogs: absence of an isotope effect in the clearance of (S)-nicotine-3',3'-d2 in humans. Biol Mass Spectrom. 1991 May;20(5):247-52.
•   Johnson MW, Bickel WK, Baker F
  Moderate drug use and delay discounting: a comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol. 2007 Apr;15(2):187-94.
•   Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB
  Predicting smoking cessation. Who will quit with and without the nicotine patch. JAMA. 1994 Feb 23;271(8):589-94.
•   Kirby KN, Petry NM, Bickel WK
  Heroin addicts have higher discount rates for delayed rewards than non-drug-using controls. J Exp Psychol Gen. 1999 Mar;128(1):78-87.
•   Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST
  A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction. 2006 Feb;101(2):192-203. Review.
•   Macklin R
  On paying money to research subjects: 'due' and 'undue' inducements. IRB. 1981 May;3(5):1-6.
•   Mokdad AH, Marks JS, Stroup DF, Gerberding JL
  Actual causes of death in the United States, 2000. JAMA. 2004 Mar 10;291(10):1238-45. Review. Erratum in: JAMA. 2005 Jan 19;293(3):298. JAMA. 2005 Jan 19;293(3):293-4.
•   Pomerleau CS, Carton SM, Lutzke ML, Flessland KA, Pomerleau OF
  Reliability of the Fagerstrom Tolerance Questionnaire and the Fagerstrom Test for Nicotine Dependence. Addict Behav. 1994 Jan-Feb;19(1):33-9.
•   Prochaska JO, DiClemente CC, Velicer WF, Rossi JS
  Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol. 1993 Sep;12(5):399-405.
•   Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C
  A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiol Biomarkers Prev. 2006 Jan;15(1):12-8.
•   Volpp KG, Pauly MV, Loewenstein G, Bangsberg D
  P4P4P: an agenda for research on pay-for-performance for patients. Health Aff (Millwood). 2009 Jan-Feb;28(1):206-14. doi: 10.1377/hlthaff.28.1.206.
•   Volpp KG, Troxel AB, Pauly MV, Glick HA, Puig A, Asch DA, Galvin R, Zhu J, Wan F, DeGuzman J, Corbett E, Weiner J, Audrain-McGovern J
  A randomized, controlled trial of financial incentives for smoking cessation. N Engl J Med. 2009 Feb 12;360(7):699-709. doi: 10.1056/NEJMsa0806819.

Financial Incentive Structures for Smoking Cessation: A Pilot Randomized Trial

Details for clinical trial NCT01303081